Cargando…
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile
AIMS: We assessed whether a novel programme to evaluate/communicate predicted coronary heart disease (CHD) risk could lower patients' predicted Framingham CHD risk vs. usual care. METHODS: The Risk Evaluation and Communication Health Outcomes and Utilization Trial was a prospective, controlled,...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658032/ https://www.ncbi.nlm.nih.gov/pubmed/18691228 http://dx.doi.org/10.1111/j.1742-1241.2008.01872.x |
_version_ | 1782165635472556032 |
---|---|
author | Benner, J S Erhardt, L Flammer, M Moller, R A Rajicic, N Changela, K Yunis, C Cherry, S B Gaciong, Z Johnson, E S Sturkenboom, M C J M García-Puig, J Girerd, X |
author_facet | Benner, J S Erhardt, L Flammer, M Moller, R A Rajicic, N Changela, K Yunis, C Cherry, S B Gaciong, Z Johnson, E S Sturkenboom, M C J M García-Puig, J Girerd, X |
author_sort | Benner, J S |
collection | PubMed |
description | AIMS: We assessed whether a novel programme to evaluate/communicate predicted coronary heart disease (CHD) risk could lower patients' predicted Framingham CHD risk vs. usual care. METHODS: The Risk Evaluation and Communication Health Outcomes and Utilization Trial was a prospective, controlled, cluster-randomised trial in nine European countries, among patients at moderate cardiovascular risk. Following baseline assessments, physicians in the intervention group calculated patients' predicted CHD risk and were instructed to advise patients according to a risk evaluation/communication programme. Usual care physicians did not calculate patients' risk and provided usual care only. The primary end-point was Framingham 10-year CHD risk at 6 months with intervention vs. usual care. RESULTS: Of 1103 patients across 100 sites, 524 patients receiving intervention, and 461 receiving usual care, were analysed for efficacy. After 6 months, mean predicted risks were 12.5% with intervention, and 13.7% with usual care [odds ratio = 0.896; p = 0.001, adjusted for risk at baseline (17.2% intervention; 16.9% usual care) and other covariates]. The proportion of patients achieving both blood pressure and low-density lipoprotein cholesterol targets was significantly higher with intervention (25.4%) than usual care (14.1%; p < 0.001), and 29.3% of smokers in the intervention group quit smoking vs. 21.4% of those receiving usual care (p = 0.04). CONCLUSIONS: A physician-implemented CHD risk evaluation/communication programme improved patients' modifiable risk factor profile, and lowered predicted CHD risk compared with usual care. By combining this strategy with more intensive treatment to reduce residual modifiable risk, we believe that substantial improvements in cardiovascular disease prevention could be achieved in clinical practice. |
format | Text |
id | pubmed-2658032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-26580322009-03-30 A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile Benner, J S Erhardt, L Flammer, M Moller, R A Rajicic, N Changela, K Yunis, C Cherry, S B Gaciong, Z Johnson, E S Sturkenboom, M C J M García-Puig, J Girerd, X Int J Clin Pract Original Paper AIMS: We assessed whether a novel programme to evaluate/communicate predicted coronary heart disease (CHD) risk could lower patients' predicted Framingham CHD risk vs. usual care. METHODS: The Risk Evaluation and Communication Health Outcomes and Utilization Trial was a prospective, controlled, cluster-randomised trial in nine European countries, among patients at moderate cardiovascular risk. Following baseline assessments, physicians in the intervention group calculated patients' predicted CHD risk and were instructed to advise patients according to a risk evaluation/communication programme. Usual care physicians did not calculate patients' risk and provided usual care only. The primary end-point was Framingham 10-year CHD risk at 6 months with intervention vs. usual care. RESULTS: Of 1103 patients across 100 sites, 524 patients receiving intervention, and 461 receiving usual care, were analysed for efficacy. After 6 months, mean predicted risks were 12.5% with intervention, and 13.7% with usual care [odds ratio = 0.896; p = 0.001, adjusted for risk at baseline (17.2% intervention; 16.9% usual care) and other covariates]. The proportion of patients achieving both blood pressure and low-density lipoprotein cholesterol targets was significantly higher with intervention (25.4%) than usual care (14.1%; p < 0.001), and 29.3% of smokers in the intervention group quit smoking vs. 21.4% of those receiving usual care (p = 0.04). CONCLUSIONS: A physician-implemented CHD risk evaluation/communication programme improved patients' modifiable risk factor profile, and lowered predicted CHD risk compared with usual care. By combining this strategy with more intensive treatment to reduce residual modifiable risk, we believe that substantial improvements in cardiovascular disease prevention could be achieved in clinical practice. Blackwell Publishing Ltd 2008-10 /pmc/articles/PMC2658032/ /pubmed/18691228 http://dx.doi.org/10.1111/j.1742-1241.2008.01872.x Text en © 2008 The Authors Journal compilation © 2008 Blackwell Publishing Ltd |
spellingShingle | Original Paper Benner, J S Erhardt, L Flammer, M Moller, R A Rajicic, N Changela, K Yunis, C Cherry, S B Gaciong, Z Johnson, E S Sturkenboom, M C J M García-Puig, J Girerd, X A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile |
title | A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile |
title_full | A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile |
title_fullStr | A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile |
title_full_unstemmed | A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile |
title_short | A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile |
title_sort | novel programme to evaluate and communicate 10-year risk of chd reduces predicted risk and improves patients' modifiable risk factor profile |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658032/ https://www.ncbi.nlm.nih.gov/pubmed/18691228 http://dx.doi.org/10.1111/j.1742-1241.2008.01872.x |
work_keys_str_mv | AT bennerjs anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT erhardtl anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT flammerm anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT mollerra anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT rajicicn anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT changelak anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT yunisc anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT cherrysb anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT gaciongz anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT johnsones anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT sturkenboommcjm anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT garciapuigj anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT girerdx anovelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT bennerjs novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT erhardtl novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT flammerm novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT mollerra novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT rajicicn novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT changelak novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT yunisc novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT cherrysb novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT gaciongz novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT johnsones novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT sturkenboommcjm novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT garciapuigj novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile AT girerdx novelprogrammetoevaluateandcommunicate10yearriskofchdreducespredictedriskandimprovespatientsmodifiableriskfactorprofile |